THE RISE OF ORPHAN DRUGS IN EUROPE VS THE UNITED STATES: COMPARING ORPHAN DRUG DESIGNATIONS BETWEEN THE EMA AND FDA

被引：1
|
作者：
Mildred, M. [1 ]
Lee, S. [1 ]
机构：
[1] Boehringer Ingelheim Ltd, Brackneil, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2005
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RSY105
引用
收藏
页码：A677 / A677
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF THE TRENDS OF ORPHAN DRUGS DESIGNATIONS AND APPROVALS IN THE UNITED STATES AND EUROPE IN ONCOLOGY
    Hanna, E.
    Korchagina, D.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A892 - A892
  • [2] ANALYSIS OF ORPHAN DRUG DESIGNATIONS AND APPROVALS IN THE UNITED STATES AND THE EUROPEAN UNION
    Almutairi, R. D.
    Alghamdi, A. A.
    Felemban, D. F.
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    Szeinbach, S. L.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A124 - A124
  • [3] Orphan drug approvals of 2014: Europe and the United States
    Norman, Peter
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (04): : 445 - 455
  • [4] Orphan drug approvals of 2015: Europe and the United States
    Norman, Peter
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (05): : 491 - 500
  • [5] ORPHAN DESIGNATIONS AND APPROVALS IN THE EU, UNITED STATES AND JAPAN
    Korchagina, D.
    Tomita, N.
    Falissard, B.
    Toumi, M.
    Tavella, F.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A341 - A341
  • [6] Orphan drugs: The current situation in the United States, Europe, and Asia
    Meyers A.S.
    [J]. Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 101 - 104
  • [7] A COMPARISON OF ORPHAN DRUGS APPROVED BY THE FDA AND EMA, 1995-2022
    Kamerikar, V
    Dheer, P.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S225 - S225
  • [8] Orphan drugs: The United States experience
    Haffner, ME
    [J]. DRUG INFORMATION JOURNAL, 1999, 33 (02): : 565 - 568
  • [9] Orphan Drugs: The United States Experience
    Marlene E. Haffner
    [J]. Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 565 - 568
  • [10] ANALYSIS OF THE ORPHAN DRUG DESIGNATIONS AND APPROVALS GRANTED BY THE EMEA AND THE USA FDA BETWEEN 2000 AND 2007
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A359 - A360
12345